Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.0850
0.00 (0.00%)
Oct 9, 2026, 1:40 PM EST
Ventripoint Diagnostics Market Cap
Ventripoint Diagnostics has a market cap or net worth of CAD 16.39 million as of October 12, 2026. It is the 40,853rd most valuable company in the world and the 1,406th biggest in Canada. Its market cap has decreased by 2.24% in one year.
Market Cap
16.39M
Enterprise Value
18.68M
Revenue
147.77K
Global Rank
Country Rank
#1,406 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since September 21, 2007, Ventripoint Diagnostics's market cap has increased from 6.82M to 16.39M, an increase of 140.22%. That is a compound annual growth rate of 4.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 16.39M | -30.40% |
| Dec 31, 2025 | 23.56M | 45.40% |
| Dec 31, 2024 | 16.20M | -64.98% |
| Dec 29, 2023 | 46.26M | 9.26% |
| Dec 30, 2022 | 42.34M | -21.10% |
| Dec 31, 2021 | 53.67M | 567.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Theralase Technologies | 54.33M |
| Cannabix Technologies | 36.95M |
| Perimeter Medical Imaging AI | 33.76M |
| Cheelcare | 31.60M |
| Conavi Medical | 20.01M |
| MedX Health | 16.40M |
| Frequency Exchange | 15.33M |
| VVT Med | 15.32M |